49 Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
49 Wealth Management's ARKG Position: Q2 2024 in Review
49 Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,459 shares — an estimated $240K sold.
49 Wealth Management first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $288K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.
- 49 Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
- 49 Wealth Management sold 8,459 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $240K.
- 49 Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
- 49 Wealth Management's ARK Genomic Revolution ETF position peaked at $288K in Q4 2023.
- 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.
Based on 49 Wealth Management's 13F filing for Q2 2024, filed 30 Jul 2024.